Alnylam is the world's leading RNAi therapeutics company and the first and only company to bring an RNAi medicine to market.

Pharmaceutical

Alnylam Pharmaceuticals

Alnylam Pharmaceuticals' headquarters in Cambridge, MA, United States

The Norton office focuses on manufacturing, quality control, and operational support for scientific and commercial initiatives.

Norton

The Zug office focuses on international medical affairs, events, compliance, and strategic analytics in the healthcare sector.

Yvonne Greenstreet

Kevin Fitzgerald

Pushkal Garg

Gabriel Robbie

Vasant Jadhav

Melissa Mclaughlin

Jeff Poulton

Christine Lindenboom

Bryan Supran

Timothy Maines

Brett Budzinski

John Gansner

Yutaka Okada

James Reindel

Tara Smith

Mike Tirozzi

Tolga Tanguler

Dennis A. Ausiello

Margaret A. Hamburg

Olivier Brandicourt

Elliott Sigal

Peter N. Kellogg

David E.i. Pyott

Colleen Reitan

Amy W. Schulman

Stuart A. Arbuckle

The Clinical Operations team at Alnylam Pharmaceuticals is essential for overseeing the planning, execution, and management of clinical trials for RNAi therapeutics. This team collaborates closely on trial design, data management, and regulatory compliance to ensure the effectiveness and safety of innovative treatments. Their comprehensive expertise supports the company's mission to develop groundbreaking medicines, while optimizing operational efficiency and maintaining high standards in clinical research.

Clinical Operations

This department focuses on research and development in biological sciences, including the study and analysis of various scientific disciplines related to biology.

Biological Sciences

This department focuses on managing client relationships and promoting business growth through effective account strategies.

Account Management

The Research and Development team at Alnylam Pharmaceuticals is dedicated to advancing the discovery and development of innovative RNAi therapeutics. This multidisciplinary team, comprising scientists, engineers, and managers, collaborates on various research initiatives, from early-stage discovery through process development and clinical research, to optimize therapeutic efficacy and safety. Their collective expertise drives the development pipeline, ensuring that cutting-edge RNAi medicines move from concept to market.

Research and Development

The Leadership Team at Alnylam Pharmaceuticals is responsible for setting the strategic direction and operational oversight of the company, ensuring alignment with its mission to pioneer RNAi therapeutics. Comprising executives from various functional areas such as research, finance, human resources, and compliance, the team collaborates to drive innovation, manage risks, and enhance organizational performance, ultimately focused on delivering transformative medicines to patients.

Leadership Team

This department focuses on ensuring the quality and compliance of products and services through systematic processes, documentation, and validation efforts.

Alnylam Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical Operations

Biological Sciences

Account Management

Research and Development

Leadership Team

Quality Assurance

Offices

Alnylam Pharmaceuticals

Org chart

Board & advisors

Teams

Clinical Operations

Biological Sciences

Account Management

Research and Development

Leadership Team

Quality Assurance

Offices

Related companies